Literature DB >> 22371110

Acute coronary syndromes: Is early abciximab beneficial in STEMI?

Alexandra King.   

Abstract

Entities:  

Year:  2012        PMID: 22371110     DOI: 10.1038/nrcardio.2012.23

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  1 in total

1.  Prehospital abciximab in ST-segment elevation myocardial infarction: results of the randomized, double-blind MISTRAL study.

Authors:  Patrick Ohlmann; Philippe Reydel; Laurent Jacquemin; Frédéric Adnet; Olivier Wolf; Jean-Claude Bartier; Anne Weiss; Frédéric Lapostolle; Cédric Gaultier; Emmanuel Salengro; Hakim Benamer; Philippe Guyon; Bernard Chevalier; Simon Catan; Patrick Ecollan; Tahar Chouihed; Michael Angioi; Michel Zupan; François Bronner; Pierre Bareiss; Gabriel Steg; Gilles Montalescot; Jean-Pierre Monassier; Olivier Morel
Journal:  Circ Cardiovasc Interv       Date:  2012-02-07       Impact factor: 6.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.